ClinicalTrials.Veeva

Menu

Manganese in Women With Encephalopathy

M

Materno-Perinatal Hospital of the State of Mexico

Status

Terminated

Conditions

Hepatic Encephalopathy

Study type

Observational

Funder types

Other

Identifiers

NCT00985010
HGDrDFF-Mn2008

Details and patient eligibility

About

Objective:

Report manganese serum levels and mortality in encephalopathic patients.

Patients and participants:

Consecutive patients aged > 18 years, with hepatic encephalopathy and informed consent signed by their families.

Interventions:

Patients' clinical characteristics as well as biochemical tests of renal function, hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze manganese levels with a graphite furnace atomic absorption spectrometer.

Hypothesis:

There is a difference in the manganese levels between male and female patients.

Enrollment

9 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consecutive patients aged > 18 years
  • With hepatic encephalopathy
  • Informed consent signed by their families

Exclusion criteria

  • Portal bypass surgery
  • Cancer of any localization
  • Known malignancy and other severe diseases which shorten life expectancy < 6 months
  • Psychiatric illness

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems